BACKGROUND: Outbreak response efforts for the 2014-15 Ebola virus disease epidemic in west Africa brought widespread transmission to an end. However, subsequent clusters of infection have occurred in the region. An Ebola virus disease cluster in Liberia in November, 2015, that was identified after a 15-year-old boy tested positive for Ebola virus infection in Monrovia, raised the possibility of transmission from a persistently infected individual. METHODS: Case investigations were done to ascertain previous contact with cases of Ebola virus disease or infection with Ebola virus. Molecular investigations on blood samples explored a potential linkage between Ebola virus isolated from cases in this November, 2015, cluster and epidemiologically linked cases from the 2014-15 west African outbreak, according to the national case database. FINDINGS: The cluster investigated was the family of the index case (mother, father, three siblings). Ebola virus genomes assembled from two cases in the November, 2015, cluster, and an epidemiologically linked Ebola virus disease case in July, 2014, were phylogenetically related within the LB5 sublineage that circulated in Liberia starting around August, 2014. Partial genomes from two additional individuals, one from each cluster, were also consistent with placement in the LB5 sublineage. Sequencing data indicate infection with a lineage of the virus from a former transmission chain in the country. Based on serology and epidemiological and genomic data, the most plausible scenario is that a female case in the November, 2015, cluster survived Ebola virus disease in 2014, had viral persistence or recurrent disease, and transmitted the virus to three family members a year later. INTERPRETATION: Investigation of the source of infection for the November, 2015, cluster provides evidence of Ebola virus persistence and highlights the risk for outbreaks after interruption of active transmission. These findings underscore the need for focused prevention efforts among survivors and sustained capacity to rapidly detect and respond to new Ebola virus disease cases to prevent recurrence of a widespread outbreak. FUNDING: US Centers for Disease Control and Prevention, Defense Threat Reduction Agency, and WHO.
BACKGROUND: Outbreak response efforts for the 2014-15 Ebola virus disease epidemic in west Africa brought widespread transmission to an end. However, subsequent clusters of infection have occurred in the region. An Ebola virus disease cluster in Liberia in November, 2015, that was identified after a 15-year-old boy tested positive for Ebola virus infection in Monrovia, raised the possibility of transmission from a persistently infected individual. METHODS: Case investigations were done to ascertain previous contact with cases of Ebola virus disease or infection with Ebola virus. Molecular investigations on blood samples explored a potential linkage between Ebola virus isolated from cases in this November, 2015, cluster and epidemiologically linked cases from the 2014-15 west African outbreak, according to the national case database. FINDINGS: The cluster investigated was the family of the index case (mother, father, three siblings). Ebola virus genomes assembled from two cases in the November, 2015, cluster, and an epidemiologically linked Ebola virus disease case in July, 2014, were phylogenetically related within the LB5 sublineage that circulated in Liberia starting around August, 2014. Partial genomes from two additional individuals, one from each cluster, were also consistent with placement in the LB5 sublineage. Sequencing data indicate infection with a lineage of the virus from a former transmission chain in the country. Based on serology and epidemiological and genomic data, the most plausible scenario is that a female case in the November, 2015, cluster survived Ebola virus disease in 2014, had viral persistence or recurrent disease, and transmitted the virus to three family members a year later. INTERPRETATION: Investigation of the source of infection for the November, 2015, cluster provides evidence of Ebola virus persistence and highlights the risk for outbreaks after interruption of active transmission. These findings underscore the need for focused prevention efforts among survivors and sustained capacity to rapidly detect and respond to new Ebola virus disease cases to prevent recurrence of a widespread outbreak. FUNDING: US Centers for Disease Control and Prevention, Defense Threat Reduction Agency, and WHO.
Authors: Fatorma K Bolay; Greg Grandits; H Clifford Lane; Stephen B Kennedy; Melvin P Johnson; Mosoka P Fallah; Barthalomew Wilson; Wissedi S Njoh; Laura A McNay; Lisa E Hensley; Elizabeth S Higgs Journal: J Infect Dis Date: 2019-04-19 Impact factor: 5.226
Authors: David X Liu; Timothy K Cooper; Donna L Perry; Louis M Huzella; Amanda M W Hischak; Randy J Hart; Nejra Isic; Russell Byrum; Danny Ragland; Marisa St Claire; Kurt Cooper; Rebecca Reeder; James Logue; Peter B Jahrling; Michael R Holbrook; Richard S Bennett; Lisa E Hensley Journal: Am J Pathol Date: 2021-10-06 Impact factor: 4.307
Authors: Elizabeth S Higgs; Dehkontee Gayedyu-Dennis; William A Fischer Ii; Martha Nason; Cavan Reilly; Abdoul Habib Beavogui; Jamila Aboulhab; Jacqueline Nordwall; Princess Lobbo; Ian Wachekwa; Huyen Cao; Tomas Cihlar; Lisa Hensley; H Clifford Lane Journal: Clin Infect Dis Date: 2021-11-16 Impact factor: 9.079
Authors: Alpha Kabinet Keita; Fara R Koundouno; Martin Faye; Ariane Düx; Julia Hinzmann; Haby Diallo; Ahidjo Ayouba; Frederic Le Marcis; Barré Soropogui; Kékoura Ifono; Moussa M Diagne; Mamadou S Sow; Joseph A Bore; Sebastien Calvignac-Spencer; Nicole Vidal; Jacob Camara; Mamadou B Keita; Annick Renevey; Amadou Diallo; Abdoul K Soumah; Saa L Millimono; Almudena Mari-Saez; Mamadou Diop; Ahmadou Doré; Fodé Y Soumah; Kaka Kourouma; Nathalie J Vielle; Cheikh Loucoubar; Ibrahima Camara; Karifa Kourouma; Giuditta Annibaldis; Assaïtou Bah; Anke Thielebein; Meike Pahlmann; Steven T Pullan; Miles W Carroll; Joshua Quick; Pierre Formenty; Anais Legand; Karla Pietro; Michael R Wiley; Noel Tordo; Christophe Peyrefitte; John T McCrone; Andrew Rambaut; Youssouf Sidibé; Mamadou D Barry; Madeleine Kourouma; Cé D Saouromou; Mamadou Condé; Moussa Baldé; Moriba Povogui; Sakoba Keita; Mandiou Diakite; Mamadou S Bah; Amadou Sidibe; Dembo Diakite; Fodé B Sako; Fodé A Traore; Georges A Ki-Zerbo; Philippe Lemey; Stephan Günther; Liana E Kafetzopoulou; Amadou A Sall; Eric Delaporte; Sophie Duraffour; Ousmane Faye; Fabian H Leendertz; Martine Peeters; Abdoulaye Toure; N' Faly Magassouba Journal: Nature Date: 2021-09-15 Impact factor: 49.962
Authors: Patrick L Iversen; Christopher D Kane; Xiankun Zeng; Rekha G Panchal; Travis K Warren; Sheli R Radoshitzky; Jens H Kuhn; Rajini R Mudhasani; Christopher L Cooper; Amy C Shurtleff; Farooq Nasar; Melek Me Sunay; Allen J Duplantier; Brett P Eaton; Elizabeth E Zumbrun; Sandra L Bixler; Shannon Martin; J Matthew Meinig; Chih-Yuan Chiang; Mariano Sanchez-Lockhart; Gustavo F Palacios; Jeffrey R Kugelman; Karen A Martins; Margaret L Pitt; Ian Crozier; David L Saunders Journal: Lancet Infect Dis Date: 2020-06-18 Impact factor: 25.071
Authors: Saskia Den Boon; Barbara J Marston; Tolbert G Nyenswah; Amara Jambai; Moumie Barry; Sakoba Keita; Kara Durski; Schabbethai S Senesie; Devin Perkins; Anita Shah; Hugh H Green; Esther L Hamblion; Margaret Lamunu; Alex Gasasira; Nuha O Mahmoud; Mamadou H Djingarey; Oliver Morgan; Ian Crozier; Christopher Dye Journal: Emerg Infect Dis Date: 2019-02-17 Impact factor: 6.883
Authors: Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn Journal: Nat Rev Dis Primers Date: 2020-02-20 Impact factor: 52.329
Authors: Marissa D Acciani; Maria F Lay Mendoza; Katherine E Havranek; Avery M Duncan; Hersha Iyer; Olivia L Linn; Melinda A Brindley Journal: J Virol Date: 2021-07-28 Impact factor: 5.103